A restructuring of the Medicare drug benefit has wiped out big drug price bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
After promising to make government healthcare data more accessible, the Biden administration now wants to clamp down
Researchers across the country fear a new proposal by the Centers for Medicare and Medicaid Services will increase fees and decrease access to data used to support major healthcare reforms.
Judge rebuffs PhRMA lawsuit over Medicare power to negotiate drug prices
It’s been a tumultuous 18 months since the passage of Medicare drug price negotiations punctured the lobbying group’s ‘aura of invincibility.’ Is it time for a policy revamp at PhRMA?
The Inflation Reduction Act’s Medicare negotiation process kicks off
The agency has rolled out sweeping changes to target end-of-life care providers that were billing for unneeded services, but some fraud hot spots continue to evade scrutiny.
Older Americans say they feel trapped in Medicare Advantage plans
After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new rules: you.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix